Clozapine influences cytoskeleton structure and calcium homeostasis in rat cerebral cortex and has a different proteomic profile than risperidone

Journal of Neurochemistry

Volumn 132, Issue 6, 2015, Pages 657-676

  Kedracka Krok, Sylwia ^a,b   Swiderska, Bianka ^a,b   Jankowska, Urszula ^a,b   Skupien Rabian, Bozena ^a,b   Solich, Joanna ^c   Buczak, Katarzyna ^a   Dziedzicka Wasylewska, Marta ^a,b  

^a Malopolska Centre of Biotechnology Department of Structural Biology ^*  (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Anti psychotics; cerebral cortex; clozapine; CRMP; proteomics; risperidone

Indexed keywords

CALCIUM BINDING PROTEIN; CELL PROTEIN; CLOZAPINE; COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; COLLAPSIN RESPONSE MEDIATOR PROTEIN 4; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 7; NEUROCALCIN; NEUROCALCIN DELTA; PLACEBO; REGULATOR PROTEIN; RISPERIDONE; STOMATIN; STOMATIN LIKE PROTEIN 2; TRANSLIN ASSOCIATED FACTOR X; UNCLASSIFIED DRUG; VISININ; VISININ LIKE PROTEIN 1; CALCIUM; NEUROLEPTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG TARGETING; MALE; NERVE CELL PLASTICITY; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEOMICS; RAT; REACTION ANALYSIS; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; UPREGULATION; ANIMAL; DRUG EFFECTS; GENETICS; HOMEOSTASIS; METABOLISM; PHYSIOLOGY; PROCEDURES; WISTAR RAT;

RATTUS;

ANIMALS; ANTIPSYCHOTIC AGENTS; CALCIUM; CEREBRAL CORTEX; CLOZAPINE; CYTOSKELETON; HOMEOSTASIS; MALE; PROTEOMICS; RATS; RATS, WISTAR; RISPERIDONE;

EID: 84924530245     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13007     Document Type: Article

References (142)

1. Aisiku O. R., Runnels L. W., and, Scarlata S., (2010) Identification of a novel binding partner of phospholipase cβ1: translin-associated factor X. PLoS ONE 5, e15001.
2. Alabed Y. Z., Pool M., Ong Tone S., Sutherland C., and, Fournier A. E., (2010) GSK3 beta regulates myelin-dependent axon outgrowth inhibition through CRMP4. J. Neurosci. 30, 5635-5643.
3. Alimohamad H., Rajakumar N., Seah Y.-H., and, Rushlow W., (2005) Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biol. Psychiatry 57, 533-542.
4. Arai M., and, Itokawa M., (2010) A hard road in psychiatric genetics: schizophrenia and DPYSL2. J. Hum. Genet. 55, 397-399.
5. Arimura N., Hattori A., Kimura T., Nakamuta S., Funahashi Y., Hirotsune S., Furuta K., Urano T., Toyoshima Y. Y., and, Kaibuchi K., (2009) CRMP-2 directly binds to cytoplasmic dynein and interferes with its activity. J. Neurochem. 111, 380-390.
6. de Bartolomeis A., Buonaguro E. F., and, Iasevoli F., (2013) Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins. Psychopharmacology 225, 1-19.
7. Bartzokis G., (2012) Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments. Neuropharmacology 62, 2137-2153.
8. Batool F., Haleem M. A., and, Haleem D. J., (2010) Acute administration of clozapine and risperidone altered dopamine metabolism more in rat caudate than in nucleus accumbens: a dose-response relationship. Sci. Pharm. 78, 259-274.
9. Beasley C. L., Pennington K., Behan A., Wait R., Dunn M. J., and, Cotter D., (2006) Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 6, 3414-3425.
10. Beaulieu J.-M., (2007) Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs. Int. J. Neuropsychopharmacol. 10, 3-6.
11. Beaulieu J.-M., (2012) A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. J. Psychiatry Neurosci. 37, 7-16.
12. Beaulieu J.-M., Marion S., Rodriguiz R. M., Medvedev I. O., Sotnikova T. D., Ghisi V., Wetsel W. C., Lefkowitz R. J., Gainetdinov R. R., and, Caron M. G., (2008) A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior. Cell 132, 125-136.
13. Bélanger M., Allaman I., and, Magistretti P. J., (2011) Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 14, 724-738.
14. Bennett M. R., (2011) Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss. Prog. Neurobiol. 95, 275-300.
15. Berridge M. J., (2014) Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia. Cell Tissue Res. 357, 477-492.
16. Biancotti J. C., Kumar S., and, de Vellis J., (2008) Activation of inflammatory response by a combination of growth factors in cuprizone-induced demyelinated brain leads to myelin repair. Neurochem. Res. 33, 2615-2628.
17. Bläser S., Jersch K., Hainmann I., Zieger W., Wunderle D., Busse A., and, Zieger B., (2003) Isolation of new splice isoforms, characterization and expression analysis of the human septin SEPT8 (KIAA0202). Gene 312, 313-320.
18. Bojarski L., Debowska K., and, Wojda U., (2010) In vitro findings of alterations in intracellular calcium homeostasis in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 34, 1367-1374.
19. Brackmann M., Zhao C., Kuhl D., Manahan-Vaughan D., and, Braunewell K.-H., (2004) MGluRs regulate the expression of neuronal calcium sensor proteins NCS-1 and VILIP-1 and the immediate early gene arg3.1/arc in the hippocampus in vivo. Biochem. Biophys. Res. Commun. 322, 1073-1079.
20. Brackmann M., Schuchmann S., Anand R., and, Braunewell K.-H., (2005) Neuronal Ca2+ sensor protein VILIP-1 affects cGMP signalling of guanylyl cyclase B by regulating clathrin-dependent receptor recycling in hippocampal neurons. J. Cell Sci. 118, 2495-2505.
21. Bradley J. E., Ramirez G., and, Hagood J. S., (2009) Roles and regulation of Thy-1, a context-dependent modulator of cell phenotype. BioFactors 35, 258-265.
22. Braunewell K. H., Dwary A. D., Richter F., Trappe K., Zhao C., Giegling I., Schönrath K., and, Rujescu D., (2011) Association of VSNL1 with schizophrenia, frontal cortical function, and biological significance for its gene product as a modulator of cAMP levels and neuronal morphology. Transl. Psychiatry 1, e22.
23. Brittain J. M., Wang Y., Eruvwetere O., and, Khanna R., (2012) Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2. FEBS Lett. 586, 3813-3818.
24. Burianek L. E., and, Soderling S. H., (2013) Under lock and key: spatiotemporal regulation of WASP family proteins coordinates separate dynamic cellular processes. Semin. Cell Dev. Biol. 24, 258-266.
25. Calabrese B., Margaret S., and, Halpain S., (2006) Development and regulation of dendritic dendritic spines: what are they? What are they for? Physiology 21, 38-47.
26. Chamovitz D. A., (2009) Revisiting the COP9 signalosome as a transcriptional regulator. EMBO Rep. 10, 352-358.
27. Chen M.-L., (2013) Two-dimensional gel electrophoresis revealed antipsychotic drugs induced protein expression modulations in C6 glioma cells. Prog. Neuropsychopharmacol. Biol. Psychiatry 40, 1-11.
28. Chew L.-J., Fusar-Poli P., and, Schmitz T., (2013) Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia. Dev. Neurosci. 35, 102-129.
29. Clark D., Dedova I., Cordwell S., and, Matsumoto I., (2006) A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. Mol. Psychiatry 11, 459-470, 423.
30. Clay H. B., Sillivan S., and, Konradi C., (2011) Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 29, 311-324.
31. Cole A. R., (2013) Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia. FEBS J. 280, 5213-5227.
32. Critchlow H. M., Maycox P. R., Skepper J. N., and, Krylova O., (2006) Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons. Mol. Cell Neurosci. 32, 356-365.
33. Da Cruz S., Parone P. A., Gonzalo P., Bienvenut W. V., Tondera D., Jourdain A., Quadroni M., and, Martinou J.-C., (2008) SLP-2 interacts with prohibitins in the mitochondrial inner membrane and contributes to their stability. Biochim. Biophys. Acta 1783, 904-911.
34. Da Cruz S., De Marchi U., Frieden M., Parone P. A., Martinou J.-C., and, Demaurex N., (2010) SLP-2 negatively modulates mitochondrial sodium-calcium exchange. Cell Calcium 47, 11-18.
35. Dent E. W., Merriam E. B., and, Hu X., (2011) The dynamic cytoskeleton: backbone of dendritic spine plasticity. Curr. Opin. Neurobiol. 21, 175-181.
36. Djagaeva I., and, Doronkin S., (2009) COP9 limits dendritic branching via Cullin3-dependent degradation of the actin-crosslinking BTB-domain protein Kelch. PLoS ONE 4, e7598.
37. Donmez G., and, Outeiro T. F., (2013) SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol. Med. 5, 344-352.
38. Duff B. J., Macritchie K. A. N., Moorhead T. W. J., Lawrie S. M., and, Blackwood D. H. R., (2013) Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review. Schizophr. Res. 147, 1-13.
39. English J. A., Dicker P., Föcking M., Dunn M. J., and, Cotter D. R., (2009) 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease. Proteomics 9, 3368-3382.
40. Engmann O., Hortobágyi T., Pidsley R., Troakes C., Bernstein H.-G., Kreutz M. R., Mill J., Nikolic M., and, Giese K. P., (2011) Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition. Brain 134, 2408-2421.
41. Fang Q., and, Lindau M., (2014) How could SNARE proteins open a fusion pore? Physiology (Bethesda) 29, 278-285.
42. Farah A., (2005) Atypicality of atypical antipsychotics. Prim. Care Companion J. Clin. Psychiatry 7, 268-274.
43. Fatemi S. H., Folsom T. D., Reutiman T. J., Pandian T., Braun N. N., and, Haug K., (2008) Chronic psychotropic drug treatment causes differential expression of connexin 43 and GFAP in frontal cortex of rats. Schizophr. Res. 104, 127-134.
44. Feresten A. H., Barakauskas V., Ypsilanti A., Barr A. M., and, Beasley C. L., (2013) Increased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness. Schizophr. Res. 150, 252-257.
45. Fic E., Kedracka-Krok S., Jankowska U., Pirog A., and, Dziedzicka-Wasylewska M., (2010) Comparison of protein precipitation methods for various rat brain structures prior to proteomic analysis. Electrophoresis 31, 3573-3579.
46. Flügge G., Araya-Callis C., Garea-Rodriguez E., Stadelmann-Nessler C., and, Fuchs E., (2014) NDRG2 as a marker protein for brain astrocytes. Cell Tissue Res. 357, 31-41.
47. Föcking M., Lopez L. M., English J. A., Dicker P., Wolff A., Brindley E., Wynne K., Cagney G., and, Cotter D. R., (2014) Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia. Mol. Psychiatry doi: 10.1038/mp.2014.63.
48. Fujiwara T., Morimoto K., Kakita A., and, Takahashi H., (2012) Dynein and dynactin components modulate neurodegeneration induced by excitotoxicity. J. Neurochem. 122, 162-174.
49. Gal J., Bang Y., and, Choi H. J., (2012) SIRT2 interferes with autophagy-mediated degradation of protein aggregates in neuronal cells under proteasome inhibition. Neurochem. Int. 61, 992-1000.
50. Gao W., (2011) Dopaminergic and glutamatergic dysfunction in the neuropathophysiology of schizophrenia. In:, Kudo, Y., Fujii, Y., (Eds.), Dopamine: Functions, Regulation and Health Effects. Nova Science Publishers, NewYork, pp. 169-194.
51. Gratten J., Wray N. R., Keller M. C., and, Visscher P. M., (2014) Large-scale genomics unveils the genetic architecture of psychiatric disorders. Nat. Neurosci. 17, 782-790.
52. Gray J. A., and, Roth B. L., (2007) Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr. Bull. 33, 1100-1119.
53. Gross G., and, Geyer M., eds (2012) Current Antipsychotics. Handbook of Experimental Pharmacology 212, Springer-Verlag, Berlin, Heidelberg.
54. Hashimoto K., (2014) Targeting of NMDA receptors in new treatments for schizophrenia. Expert Opin. Ther. Targets 18, 1049-1063.
55. de las Heras R., Depaz I., Jaquet V., Kroon P., and, Wilce P. A., (2007) Neuronal protein 22 colocalises with both the microtubule and microfilament cytoskeleton in neurite-like processes. Brain Res. 1128, 12-20.
56. Hermosilla T., Muñoz D., Herrera-Molina R., Valdivia A., Muñoz N., Nham S.-U., Schneider P., Burridge K., Quest A. F. G., and, Leyton L., (2008) Direct Thy-1/alphaVbeta3 integrin interaction mediates neuron to astrocyte communication. Biochim. Biophys. Acta 1783, 1111-1120.
57. Herrera-Molina R., Frischknecht R., Maldonado H., Seidenbecher C. I., Gundelfinger E. D., Hetz C., Aylwin M. D. L. L., Schneider P., Quest A. F. G., and, Leyton L., (2012) Astrocytic αVβ3 integrin inhibits neurite outgrowth and promotes retraction of neuronal processes by clustering Thy-1. PLoS ONE 7, e34295.
58. Ito M., Depaz I., Wilce P., Suzuki T., Niwa S., and, Matsumoto I., (2005) Expression of human neuronal protein 22, a novel cytoskeleton-associated protein, was decreased in the anterior cingulate cortex of schizophrenia. Neurosci. Lett. 378, 125-130.
59. Ito H., Atsuzawa K., Morishita R., Usuda N., et al,. (2009) Sept8 controls the binding of vesicle-associated membrane protein 2 to synaptophysin. J. Neurochem. 108, 867-880.
60. Ivings L., Pennington S. R., Jenkins R., Weiss J. L., and, Burgoyne R. D., (2002) Identification of Ca2+ dependent binding partners for the neuronal calcium sensor protein neurocalcin δ: interaction with actin, clathrin and tubulin. Biochem. J. 608, 599-608.
61. Javitt D. C., (2010) Glutamatergic theories of schizophrenia. Isr. J. Psychiatry Relat. Sci. 47, 4-16.
62. Johnson R. D., Oliver P. L., and, Davies K. E., (2008) SNARE proteins and schizophrenia: linking synaptic and neurodevelopmental hypotheses. Acta Biochim. Pol. 55, 619-628.
63. Jüch M., Smalla K.-H., Kähne T., Lubec G., Tischmeyer W., Gundelfinger E. D., and, Engelmann M., (2009) Congenital lack of nNOS impairs long-term social recognition memory and alters the olfactory bulb proteome. Neurobiol. Learn. Mem. 92, 469-484.
64. Kapur S., and, Seeman P., (2001) Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: a new hypothesis. Am. J. Psychiatry 158, 360-369.
65. Kaufman R. J., and, Malhotra J. D., (2014) Calcium trafficking integrates endoplasmic reticulum function with mitochondrial bioenergetics. Biochim. Biophys. Acta 1843, 2233-2239.
66. Kawano Y., Yoshimura T., Tsuboi D., Kaneko-kawano T., Shirataki H., and, Kawabata S., (2005) CRMP-2 is involved in kinesin-1-dependent transport of the Sra-1/WAVE1 complex and axon formation. Mol. Cell. Biol. 25, 9920-9935.
67. Kong M., Muñoz N., Valdivia A., Alvarez A., Herrera-Molina R., Cárdenas A., Schneider P., Burridge K., Quest A. F. G., and, Leyton L., (2013) Thy-1-mediated cell-cell contact induces astrocyte migration through the engagement of αVβ3 integrin and syndecan-4. Biochim. Biophys. Acta 1833, 1409-1420.
68. Korobova F., and, Svitkina T., (2010) Molecular architecture of synaptic actin cytoskeleton in hippocampal neurons reveals a mechanism of dendritic spine morphogenesis. Mol. Biol. Cell 21, 165-176.
69. Kowara R., Ménard M., Brown L., and, Chakravarthy B., (2007) Co-localization and interaction of DPYSL3 and GAP43 in primary cortical neurons. Biochem. Biophys. Res. Commun. 363, 190-193.
70. Krishnan A., Venkataraman V., Fik-Rymarkiewicz E., Duda T., and, Sharma R. K., (2004) Structural, biochemical, and functional characterization of the calcium sensor neurocalcin delta in the inner retinal neurons and its linkage with the rod outer segment membrane guanylate cyclase transduction system. Biochemistry 43, 2708-2723.
71. Kroeze W. K., Hufeisen S. J., Popadak B. A., Renock S. M., Steinberg S., Ernsberger P., Jayathilake K., Meltzer H. Y., and, Roth B. L., (2003) H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28, 519-526.
72. Leermakers F. A. M., and, Zhulina E. B., (2010) How the projection domains of NF-L and alpha-internexin determine the conformations of NF-M and NF-H in neurofilaments. Eur. Biophys. J. 39, 1323-1334.
73. Lewis D. A., Curley A. A., Glausier J. R., and, Volk D. W., (2012) Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 35, 57-67.
74. Li W., Zhang B., Tang J., Cao Q., Wu Y., Wu C., Guo J., Ling E.-A., and, Liang F., (2007a) Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating alpha-tubulin. J. Neurosci. 27, 2606-2616.
75. Li X., Rosborough K. M., Friedman A. B., Zhu W., and, Roth K. A., (2007b) Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. Int. J. Neuropsychopharmacol. 10, 7-19.
76. Li C., Pan W., Braunewell K. H., and, Ames J. B., (2011) Structural analysis of Mg2+ and Ca2+ binding, myristoylation, and dimerization of the neuronal calcium sensor and visinin-like protein 1 (VILIP-1). J. Biol. Chem. 286, 6354-6366.
77. Lovestone S., Killick R., Di Forti M., and, Murray R., (2007) Schizophrenia as a GSK-3 dysregulation disorder. Trends Neurosci. 30, 142-149.
78. Ma K., Yang L., Chen H., and, Lu Y., (2013) Activation of muscarinic receptors inhibits glutamate-induced GSK-3β overactivation in PC12 cells. Acta Pharmacol. Sin. 34, 886-892.
79. Machnicka B., Czogalla A., Hryniewicz-Jankowska A., Bogusławska D. M., Grochowalska R., Heger E., and, Sikorski A. F., (2014) Spectrins: a structural platform for stabilization and activation of membrane channels, receptors and transporters. Biochim. Biophys. Acta 1838, 620-634.
80. Majava V., Löytynoja N., Chen W.-Q., Lubec G., and, Kursula P., (2008) Crystal and solution structure, stability and post-translational modifications of collapsin response mediator protein 2. FEBS J. 275, 4583-4596.
81. Manji H., Kato T., Di Prospero N. A., Ness S., Beal M. F., Krams M., and, Chen G., (2012) Impaired mitochondrial function in psychiatric disorders. Nat. Rev. Neurosci. 13, 293-307.
82. Mao Y., Ge X., Frank C. L., Madison J. M., Koehler A. N., Doud M. K., Tassa C., et al,. (2009) Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 136, 1017-1031.
83. Martins-de-Souza D., Gattaz W. F., Schmitt A., Maccarrone G., Hunyadi-Gulyás E., Eberlin M. N., Souza G. H. M. F., et al,. (2009a) Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J. Psychiatr. Res. 43, 978-986.
84. Martins-de-Souza D., Gattaz W. F., Schmitt A., Novello J. C., Marangoni S., Turck C. W., and, Dias-Neto E., (2009b) Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry 9, 17.
85. Martins-de-Souza D., Gattaz W. F., Schmitt A., Rewerts C., Marangoni S., Novello J. C., Maccarrone G., Turck C. W., and, Dias-Neto E., (2009c) Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J. Neural. Transm. 116, 275-289.
86. Maxwell M. M., Tomkinson E. M., Nobles J., Wizeman J. W., Amore A. M., Quinti L., Chopra V., Hersch S. M., and, Kazantsev A. G., (2011) The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum. Mol. Genet. 20, 3986-3996.
87. McLean S. L., Neill J. C., Idris N. F., Marston H. M., Wong E. H. F., and, Shahid M., (2010) Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat. Behav. Brain Res. 214, 240-247.
88. McNair K., Broad J., Riedel G., Davies C. H., and, Cobb S. R., (2007) Global changes in the hippocampal proteome following exposure to an enriched environment. Neuroscience 145, 413-422.
89. Meltzer H. Y., (2012) Clozapine: balancing safety with superior antipsychotic efficacy. Clin. Schizophr. Relat. Psychoses 6, 134-144.
90. Meltzer H. Y., (2013) Update on typical and atypical antipsychotic drugs. Annu. Rev. Med. 64, 393-406.
91. Miyamoto S., Miyake N., Jarskog L. F., Fleischhacker W. W., and, Lieberman J. A., (2012) Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol. Psychiatry 17, 1206-1227.
92. Morita A., Yamashita N., Sasaki Y., Uchida Y., Nakajima O., Nakamura F., Yagi T., et al,. (2006) Regulation of dendritic branching and spine maturation by semaphorin3A-Fyn signaling. J. Neurosci. 26, 2971-2980.
93. Mráček T., Drahota Z., and, Houštěk J., (2013) The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues. Biochim. Biophys. Acta 1827, 401-410.
94. Murk K., Blanco Suarez E. M., Cockbill L. M. R., Banks P., and, Hanley J. G., (2013) The antagonistic modulation of Arp2/3 activity by N-WASP, WAVE2 and PICK1 defines dynamic changes in astrocyte morphology. J. Cell Sci. 126, 3873-3883.
95. Nesvaderani M., Matsumoto I., and, Sivagnanasundaram S., (2009) Anterior hippocampus in schizophrenia pathogenesis: molecular evidence from a proteome study. Aust. N. Z. J. Psychiatry 43, 310-322.
96. Nishiyama M., Hoshino A., and, Tsai L., (2003) Cyclic AMP/GMP-dependent modulation of Ca+plus; channels sets the polarity of nerve growth-cone turning. Nature 423.
97. Palmieri F., (2004) The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch. 447, 689-709.
98. Pape M., Doxakis E., Reiff T., Duong C. V., Davies A., Geissen M., and, Rohrer H., (2008) A function for the calponin family member NP25 in neurite outgrowth. Dev. Biol. 321, 434-443.
99. Park H. J., Park H.-W., Lee S.-J., Arevalo J. C., Park Y.-S., Lee S.-P., Paik K.-S., Chao M. V., and, Chang M.-S., (2010) Ankyrin repeat-rich membrane spanning/Kidins220 protein interacts with mammalian Septin 5. Mol. Cells 30, 143-148.
100. Park J., Sung J. Y., Park J., Song W.-J., Chang S., and, Chung K. C., (2012) Dyrk1A negatively regulates the actin cytoskeleton through threonine phosphorylation of N-WASP. J. Cell Sci. 125, 67-80.
101. Patel V. P., and, Chu C. T., (2014) Decreased SIRT2 activity leads to altered microtubule dynamics in oxidatively-stressed neuronal cells: implications for Parkinson's disease. Exp. Neurol. 257, 170-181.
102. Peche V. S., Holak T. A., Burgute B. D., Kosmas K., Kale S. P., Wunderlich F. T., Elhamine F., et al,. (2013) Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy. Cell. Mol. Life Sci. 70, 527-543.
103. Pennington K., Beasley C. L., Dicker P., Fagan A., English J., Pariante C. M., Wait R., Dunn M. J., and, Cotter D. R., (2008a) Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol. Psychiatry 13, 1102-1117.
104. Pennington K., Dicker P., Dunn M. J., and, Cotter D. R., (2008b) Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia. Proteomics 8, 5097-5107.
105. Penzes P., Cahill M. E., Jones K. A., VanLeeuwen J.-E., and, Woolfrey K. M., (2011) Dendritic spine pathology in neuropsychiatric disorders. Nat. Neurosci. 14, 285-293.
106. Popkirov S. G., and, Manahan-Vaughan D., (2011) Involvement of the metabotropic glutamate receptor mGluR5 in NMDA receptor-dependent, learning-facilitated long-term depression in CA1 synapses. Cereb. Cortex 21, 501-509.
107. Prabakaran S., Swatton J. E., Ryan M. M., Huffaker S. J., Huang J. T.-J., Griffin J. L., Wayland M., et al,. (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 9, 684-697, 643.
108. Rege T. A., and, Hagood J. S., (2006) Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 20, 1045-1054.
109. Ritsner M., ed. (2011) Handbook of Schizophrenia Spectrum Disorders, vol. II. Springer, Netherlands, Dordrecht.
110. Rosslenbroich V., Dai L., Baader S. L., Noegel A. A., Gieselmann V., and, Kappler J., (2005) Collapsin response mediator protein-4 regulates F-actin bundling. Exp. Cell Res. 310, 434-444.
111. Schmidt E. F., and, Strittmatter S. M., (2007) The CRMP family of proteins and their role in Sema3A signaling. Adv. Exp. Med. Biol. 600, 1-11.
112. Sharifi K., Morihiro Y., Maekawa M., Yasumoto Y., Hoshi H., Adachi Y., Sawada T., et al,. (2011) FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation. Histochem. Cell Biol. 136, 501-513.
113. Shirazi-Southall S., Rodriguez D., and, Nomikos G., (2001) Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26, 583-594.
114. Sivagnanasundaram S., Crossett B., Dedova I., Cordwell S., and, Matsumoto I., (2007) Abnormal pathways in the genu of the corpus callosum in schizophrenia pathogenesis: a proteome study. Proteomics Clin. Appl. 1, 1291-1305.
115. Smalla K.-H., Mikhaylova M., Sahin J., Bernstein H.-G., Bogerts B., Schmitt A., der van Schors R., et al,. (2008) A comparison of the synaptic proteome in human chronic schizophrenia and rat ketamine psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia. Mol. Psychiatry 13, 878-896.
116. Southwood C. M., Peppi M., Dryden S., Tainsky M. A., and, Gow A., (2007) Microtubule deacetylases, SirT2 and HDAC6, in the nervous system. Neurochem. Res. 32, 187-195.
117. Spiliotis E. T., (2010) Regulation of microtubule organization and functions by septin GTPases. Cytoskeleton (Hoboken) 67, 339-345.
118. Steffek A. E., McCullumsmith R. E., Haroutunian V., and, Meador-Woodruff J. H., (2008) Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia. Schizophr. Res. 103, 71-82.
119. Sutton L. P., and, Rushlow W. J., (2011) The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling. Neuroscience 199, 116-124.
120. Sytnyk V., Leshchyns'ka I., Dityatev A., and, Schachner M., (2004) Trans-Golgi network delivery of synaptic proteins in synaptogenesis. J. Cell Sci. 117, 381-388.
121. Takahashi K., Saitoh A., Yamada M., Iwai T., Inagaki M., and, Yamada M., (2012) Dexamethasone indirectly induces Ndrg2 expression in rat astrocytes. J. Neurosci. Res. 90, 160-166.
122. Takeichi T., Takarada-Iemata M., Hashida K., Sudo H., Okuda T., Kokame K., Hatano T., et al,. (2011) The effect of Ndrg2 expression on astroglial activation. Neurochem. Int. 59, 21-27.
123. Tandon R., (2011) Antipsychotics in the treatment of schizophrenia: an overview. J. Clin. Psychiatry 72 (Suppl 1), 4-8.
124. Toro C. T., Hallak J. E. C., Dunham J. S., and, Deakin J. F. W., (2006) Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder. Neurosci. Lett. 404, 276-281.
125. Tsermpini E. E., Assimakopoulos K., Bartsakoulia M., Iconomou G., Papadima E. M., Mitropoulos K., Squassina A., and, Patrinos G. P., (2014) Individualizing clozapine and risperidone treatment for schizophrenia patients. Pharmacogenomics 15, 95-110.
126. Vercauteren F. G. G., Flores G., Ma W., Chabot J.-G., Geenen L., Clerens S., Fazel A., et al,. (2007) An organelle proteomic method to study neurotransmission-related proteins, applied to a neurodevelopmental model of schizophrenia. Proteomics 7, 3569-3579.
127. Villalobos C., and, Andrade R., (2010) Visinin-like neuronal calcium sensor proteins regulate the slow calcium-activated afterhyperpolarizing current in the rat cerebral cortex. J. Neurosci. 30, 14361-14365.
128. Watanabe A., Toyota T., Owada Y., Hayashi T., Iwayama Y., Matsumata M., Ishitsuka Y., et al,. (2007) Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol. 5, e297.
129. Wegner A. M., Nebhan C. A., Hu L., Majumdar D., Meier K. M., Weaver A. M., and, Webb D. J., (2008) N-wasp and the arp2/3 complex are critical regulators of actin in the development of dendritic spines and synapses. J. Biol. Chem. 283, 15912-15920.
130. Welinder C., and, Ekblad L., (2011) Coomassie staining as loading control in western blot analysis. J. Proteome Res. 10, 1416-1419.
131. Wesseling H., Chan M. K., Tsang T. M., Ernst A., Peters F., Guest P. C., Holmes E., and, Bahn S., (2013) A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology. Neuropsychopharmacology 38, 2532-2544.
132. Wood S. J., Yücel M., Pantelis C., and, Berk M., (2009) Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress. Ann. Acad. Med. Singapore 38, 396-401.
133. Woodward N. D., Purdon S. E., Meltzer H. Y., and, Zald D. H., (2005) A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int. J. Neuropsychopharmacol. 8, 457-472.
134. Xu K., Zhong G., and, Zhuang X., (2013) Actin, spectrin, and associated proteins form a periodic cytoskeletal structure in axons. Science 339, 452-456.
135. Yamashita N., and, Goshima Y., (2012) Collapsin response mediator proteins regulate neuronal development and plasticity by switching their phosphorylation status. Mol. Neurobiol. 45, 234-246.
136. Yamashita N., Ohshima T., Nakamura F., Kolattukudy P., Honnorat J., Mikoshiba K., and, Goshima Y., (2012) Phosphorylation of CRMP2 (collapsin response mediator protein 2) is involved in proper dendritic field organization. J. Neurosci. 32, 1360-1365.
137. Yamatani H., Kawasaki T., Mita S., Inagaki N., and, Hirata T., (2010) Proteomics analysis of the temporal changes in axonal proteins during maturation. Dev. Neurobiol. 70, 523-537.
138. Young J. K., Heinbockel T., and, Gondré-Lewis M. C., (2013) Astrocyte fatty acid binding protein-7 is a marker for neurogenic niches in the rat hippocampus. Hippocampus 23, 1476-1483.
139. Zhao C., and, Braunewell K.-H., (2008) Expression of the neuronal calcium sensor visinin-like protein-1 in the rat hippocampus. Neuroscience 153, 1202-1212.
140. Zhao C., Anand R., and, Braunewell K.-H., (2009) Nicotine-induced Ca2+-myristoyl switch of neuronal Ca2+ sensor VILIP-1 in hippocampal neurons: a possible crosstalk mechanism for nicotinic receptors. Cell. Mol. Neurobiol. 29, 273-286.
141. Zhou K., Yang Y., Gao L., He G., Li W., Tang K., Ji B., et al,. (2012) NMDA receptor hypofunction induces dysfunctions of energy metabolism and semaphorin signaling in rats: a synaptic proteome study. Schizophr. Bull. 38, 579-591.
142. Zhu H., Zhao L., Wang E., Dimova N., Liu G., Feng Y., and, Cambi F., (2012) The QKI-PLP pathway controls SIRT2 abundance in CNS myelin. Glia 60, 69-82.